Systems Therapeutics for Lung Cancer

Our new work on systems biology of lung cancer has proposed a precision oncology platform for treatment pf NSCLC by allupurinol and a JAK2 inhibitor based on gene signatures. This work is now available on bioRxiv.

Featured Posts
Recent Posts
Archive
Search By Tags
Follow Me
  • Facebook Basic Square
  • Twitter Basic Square